NeuroSense Therapeutics press releases
The latest press releases from NeuroSense Therapeutics (NASDAQ: NRSN), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each NeuroSense Therapeutics release within minutes of publication.
- Listing
- NASDAQ: NRSN
- Latest release
- Oct 29, 2026
- On this page
- 6 newest releases
Latest NeuroSense Therapeutics press releases
- NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026
Presentation will highlight how findings from the PARADIGM program are informing the clinical development strategy for PARAGON CAMBRIDGE, Mass., Oct. 29, 2026 /PRNewswire/ -- NeuroSense Therapeutics L…
- NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
Management will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026 and will be available for one-on-one investor meetings during the conference CAMBRIDGE, Mas…
- NeuroSense Provides Business Update and Progress for the First Half of 2026
CAMBRIDGE, Mass., Sept. 25, 2026 /PRNewswire/ -- Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing disease-modifying t…
The first 3 are open to everyone. A free account shows the rest and emails you the next NeuroSense Therapeutics release the minute it is out.
PPN World is independent and not affiliated with NeuroSense Therapeutics. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find NeuroSense Therapeutics press releases?+
How do I get an alert when NeuroSense Therapeutics publishes a press release?+
Is this NeuroSense Therapeutics's official newsroom?+
Know the minute NeuroSense Therapeutics publishes
Watch NeuroSense Therapeutics, its competitors and its sector in one live feed, with email alerts — on the free plan.